Article Text
Abstract
This paper examines the UK Supreme Court decision in Montgomery v Lanarkshire Health Board, which deals with consent and information disclosure in medical treatment and care. It signaled a move away from a ‘doctor knows best’ approach to one that focuses on disclosing information to which particular patients would attach significance. Notwithstanding concerns about increased litigation and loss of professional autonomy, the reality is that the decision will make little difference to healthcare practice and consent in the UK. The Supreme Court has endorsed a view that most lawyers and doctors thought already prevailed, and it reflects the General Medical Council's guidance on the issue of consent in any case. Given recent healthcare scandals in the National Health Service (NHS), the Supreme Court's legal recognition of the importance of recognizing patient autonomy in disclosing risks about medical treatment and care is a welcome development.
- Ethics
Statistics from Altmetric.com
Linked Articles
- Current controversy
- The concise argument
Read the full text or download the PDF:
Other content recommended for you
- Montgomery, informed consent and causation of harm: lessons from Australia or a uniquely English approach to patient autonomy?
- ‘Bolam’ to ‘Montgomery’ is result of evolutionary change of medical practice towards ‘patient-centred care’
- Update on the UK law on consent
- Vulnerability, therapeutic misconception and informed consent: is there a need for special treatment of pregnant women in fetus-regarding clinical trials?
- Disclosure and consent: ensuring the ethical provision of information regarding childbirth
- Montgomery on informed consent: an inexpert decision?
- Valid consent to medical treatment
- Ethics briefings
- One step forward, two steps back? The GMC, the common law and ‘informed’ consent
- GMC confidentiality guidance 2017